360 related articles for article (PubMed ID: 17397003)
41. 3-Hydroxyphthaloyl beta-lactoglobulin. IV Antiviral activity in the mouse model of genital herpesvirus infection.
Kokuba H; Aurelian L; Neurath AR
Antivir Chem Chemother; 1998 Jul; 9(4):353-7. PubMed ID: 9875414
[TBL] [Abstract][Full Text] [Related]
42. Case report: symptomatic oral herpes simplex virus type 2 and asymptomatic genital shedding.
Olin L; Wald A
Herpes; 2006 May; 13(1):25-6. PubMed ID: 16733000
[TBL] [Abstract][Full Text] [Related]
43. Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes.
Bernstein DI; Cardin RD; Bravo FJ; Earwood J; Clark JR; Li Y; Mishra P; Li C; Nayak BP; Miller AT; Wu TY; Cooke MP; Valiante NM
Antivir Chem Chemother; 2014 Apr; 23(5):189-96. PubMed ID: 23232327
[TBL] [Abstract][Full Text] [Related]
44. Three phase III randomized controlled trials of topical resiquimod 0.01-percent gel to reduce anogenital herpes recurrences.
Mark KE; Spruance S; Kinghorn GR; Sacks SL; Slade HB; Meng TC; Selke S; Magaret A; Wald A
Antimicrob Agents Chemother; 2014 Sep; 58(9):5016-23. PubMed ID: 24709264
[TBL] [Abstract][Full Text] [Related]
45. Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy.
Posavad CM; Wald A; Kuntz S; Huang ML; Selke S; Krantz E; Corey L
J Infect Dis; 2004 Aug; 190(4):693-6. PubMed ID: 15272395
[TBL] [Abstract][Full Text] [Related]
46. Herpes simplex virus shedding and plasma human immunodeficiency virus RNA levels in coinfected women.
Augenbraun M; Corey L; Reichelderfer P; Wright DJ; Burns D; Koelle DM; Robison E; Cohen M;
Clin Infect Dis; 2001 Sep; 33(6):885-90. PubMed ID: 11512094
[TBL] [Abstract][Full Text] [Related]
47. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.
Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L
J Infect Dis; 2002 Dec; 186(12):1718-25. PubMed ID: 12447756
[TBL] [Abstract][Full Text] [Related]
48. An update on short-course episodic and prevention therapies for herpes genitalis.
Corey L; Bodsworth N; Mindel A; Patel R; Schacker T; Stanberry L
Herpes; 2007 Jun; 14 Suppl 1():5A-11A. PubMed ID: 17877886
[TBL] [Abstract][Full Text] [Related]
49. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
Leone P
Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897
[TBL] [Abstract][Full Text] [Related]
50. Subclinical Genital Herpes Shedding in HIV/Herpes Simplex Virus 2-Coinfected Women during Antiretroviral Therapy Is Associated with an Increase in HIV Tissue Reservoirs and Potentially Promotes HIV Evolution.
Stinn T; Kuntz S; Varon D; Huang ML; Selke S; Njikan S; Ford ES; Dragavon J; Coombs RW; Johnston C; Bull ME
J Virol; 2020 Dec; 95(1):. PubMed ID: 33028713
[TBL] [Abstract][Full Text] [Related]
51. High incidence of genotypic variance between sequential herpes simplex virus type 2 isolates from HIV-1-seropositive patients with recurrent genital herpes.
Roest RW; Maertzdorf J; Kant M; van der Meijden WI; Osterhaus AD; Verjans GM
J Infect Dis; 2006 Oct; 194(8):1115-8. PubMed ID: 16991086
[TBL] [Abstract][Full Text] [Related]
52. [Herpes simplex virus type 1 and 2 (HSV-1,2) DNA detection by PCR during genital herpes].
Susloparov MA; Susloparov IM; Zagoruĭko TIu; Noskova NV; Makhova NM
Mol Gen Mikrobiol Virusol; 2006; (1):38-41. PubMed ID: 16512611
[TBL] [Abstract][Full Text] [Related]
53. Herpes simplex virus type 2 transmission: risk factors and virus shedding.
Wald A
Herpes; 2004 Aug; 11 Suppl 3():130A-137A. PubMed ID: 15319082
[TBL] [Abstract][Full Text] [Related]
54. Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modelling.
Crespi CM; Cumberland WG; Wald A; Corey L; Blower S
Sex Transm Infect; 2007 Aug; 83(5):359-64. PubMed ID: 17475687
[TBL] [Abstract][Full Text] [Related]
55. Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in Uganda.
Phipps W; Nakku-Joloba E; Krantz EM; Selke S; Huang ML; Kambugu F; Orem J; Casper C; Corey L; Wald A
J Infect Dis; 2016 Feb; 213(3):439-47. PubMed ID: 26486633
[TBL] [Abstract][Full Text] [Related]
56. Introduction: Is viral shedding a surrogate marker for transmission of genital herpes?
Sacks SL; Griffiths PD; Corey L; Cohen C; Cunningham A; Dusheiko GM; Self S; Spruance S; Stanberry LR; Wald A; Whitley RJ
Antiviral Res; 2004 Aug; 63 Suppl 1():S3-9. PubMed ID: 15450380
[TBL] [Abstract][Full Text] [Related]
57. Effect of resveratrol on herpes simplex virus vaginal infection in the mouse.
Docherty JJ; Fu MM; Hah JM; Sweet TJ; Faith SA; Booth T
Antiviral Res; 2005 Sep; 67(3):155-62. PubMed ID: 16125258
[TBL] [Abstract][Full Text] [Related]
58. Acyclovir suppression to prevent recurrent genital herpes at delivery.
Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
Infect Dis Obstet Gynecol; 2002; 10(2):71-7. PubMed ID: 12530483
[TBL] [Abstract][Full Text] [Related]
59. The effects of daily distress and personality on genital HSV shedding and lesions in a randomized, double-blind, placebo-controlled, crossover trial of acyclovir in HSV-2 seropositive women.
Strachan E; Saracino M; Selke S; Magaret A; Buchwald D; Wald A
Brain Behav Immun; 2011 Oct; 25(7):1475-81. PubMed ID: 21693182
[TBL] [Abstract][Full Text] [Related]
60. HIV-1 and herpes simplex virus type-2 genital shedding among co-infected women using self-collected swabs in Chiang Rai, Thailand.
Forhan SE; Dunne EF; Sternberg MR; Whitehead SJ; Leelawiwat W; Thepamnuay S; Chen C; Evans-Strickfaden T; McNicholl JM; Markowitz LE
Int J STD AIDS; 2012 Aug; 23(8):560-4. PubMed ID: 22930292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
